MEETINGS - US FDA 510(K) Submissions for Medical Devices, a Management Forum seminar (UK) January 2002:
This article was originally published in Clinica
US FDA 510(K) Submissions for Medical Devices, a Management Forum seminar, will be held on January 17 2002 at the Harrington Hall, London. The objective of the seminar is to provide practical information regarding the preparation and content of pre-market notifications, 510(k)s. This will include an insight into the FDA's motivation when handling applications; the variety of 510(k)s available; alternative review mechanisms; implications of the mutual recognition programme and the procedures to be followed when a design or process alters. Further information from Management Forum on tel: +44 (0)1483 570 099; fax: +44 (0)1483 536 424; email firstname.lastname@example.org www.management-forum.co.uk
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.